CIK 0001729427 · Non-accelerated filer<br>Smaller reporting company
CNS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CNSP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 822318545
- Phone
- 1-800-946-9185
- Business address
- 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
- 8-K Event Executive or director change · Shareholder vote results
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 2,000 shares at $5.00 ($10,000)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise CEO and President acquired 4,750 shares (option exercise)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy Director bought 7,100 shares at $4.79 ($34,002)
- D Other Notice of Sales of Unregistered Securities
- S-3 Offering Registration Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Unregistered share sale · Executive or director change
- 10-K/A Report 10-K/A
Page 1 of 20 · 390 filings